Spago Nanomedical in media

• 24 Oct, 2023
  Intervju med VD Mats Hansen – Börsvärlden
• 23 Oct, 2023
  Spago Nanomedical’s promising cancer therapy approved for phase I/IIa – BioStock
• 29 Jun, 2023
  Spago Nanomedical’s SAB on Tumorad’s potential – BioStock
• 16 May, 2023
  Tumorad clinical start around the corner for Spago Nanomedical – BioStock
• 8 Feb, 2023
  Spago Nanomedical reports advancement – BioStock
• 12 Jan, 2023
  Spago Nanomedical publishes positive preclinical data – BioStock
• 8 Dec, 2022
  Spago Nanomedical starts phase IIa study in endometriosis – BioStock
• 13 Sep, 2022
  Spago Nanomedical in hot area – BioStock
• 26 Aug, 2022
  Spago Nanomedical on the autumn newsflow – BioStock
• 5 Jul, 2022
  Spago Nanomedical progresses towards clinical phase with Tumorad – Biostock